411 related articles for article (PubMed ID: 12031892)
1. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
[TBL] [Abstract][Full Text] [Related]
2. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
[TBL] [Abstract][Full Text] [Related]
3. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.
Turnbull S; Tabner BJ; El-Agnaf OM; Moore S; Davies Y; Allsop D
Free Radic Biol Med; 2001 May; 30(10):1163-70. PubMed ID: 11369507
[TBL] [Abstract][Full Text] [Related]
4. A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synuclein.
Tabner BJ; Turnbull S; King JE; Benson FE; El-Agnaf OM; Allsop D
Free Radic Res; 2006 Jul; 40(7):731-9. PubMed ID: 16984000
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
Free Radic Biol Med; 2002 Mar; 32(6):544-50. PubMed ID: 11958955
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
7. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
8. The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro.
Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
Biochimie; 2002 Jul; 84(7):625-31. PubMed ID: 12453634
[TBL] [Abstract][Full Text] [Related]
9. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
[TBL] [Abstract][Full Text] [Related]
10. Copper(II)-induced self-oligomerization of alpha-synuclein.
Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
[TBL] [Abstract][Full Text] [Related]
11. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Paik SR; Shin HJ; Lee JH
Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
[TBL] [Abstract][Full Text] [Related]
12. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
13. New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-traps.
Turnbull S; Tabner BJ; El-Agnaf OM; Twyman LJ; Allsop D
Free Radic Biol Med; 2001 May; 30(10):1154-62. PubMed ID: 11369506
[TBL] [Abstract][Full Text] [Related]
14. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.
Hashimoto M; Hsu LJ; Xia Y; Takeda A; Sisk A; Sundsmo M; Masliah E
Neuroreport; 1999 Mar; 10(4):717-21. PubMed ID: 10208537
[TBL] [Abstract][Full Text] [Related]
16. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E
Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
[TBL] [Abstract][Full Text] [Related]
17. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
Krüger R; Müller T; Riess O
J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.
Ho CY; Troncoso JC; Knox D; Stark W; Eberhart CG
Brain Pathol; 2014 Jan; 24(1):25-32. PubMed ID: 23714377
[TBL] [Abstract][Full Text] [Related]
19. Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.
Windisch M; Hutter-Paier B; Rockenstein E; Hashimoto M; Mallory M; Masliah E
J Mol Neurosci; 2002; 19(1-2):63-9. PubMed ID: 12212795
[TBL] [Abstract][Full Text] [Related]
20. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
Atsmon-Raz Y; Miller Y
ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]